Publisher: DelveInsight
Category: Diseases & Conditions

Diseases & Conditions market research reports by DelveInsight

(1,146 reports matching your criteria)
    • Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Pipeline Insight, 2024

      Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Pipeline Insight, 2024 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Overview ""Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical developme ... Read More

    • Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024

      Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Hepatitis C Virus Infection pipeline landscape. It covers the pipel ... Read More

    • Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024

      Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Hepatitis Delta Virus (HDV) Infection pipeline ... Read More

    • Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

      Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of pulmonary arterial hypertension has been increasing due to the rising frequency of cardiovascular diseases and arterial hypertension. Furthermore, the growing adult population, which is more ... Read More

    • Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034

      Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Attributed to the rising diagnosed prevalent cases and increasing awareness, the Molybdenum Cofactor Deficiency Type A (MoCoD-A) market was valued at nearly USD 12 million in 2023 and is expected to exp ... Read More

    • Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024

      Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024 Adult T-Cell Leukemia-Lymphoma Overview ""Adult T-Cell Leukemia-Lymphoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adult T-Cell Leukem ... Read More

    • Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024

      Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024 Advanced Breast Cancer in Premenopausal Women Overview ""Advanced Breast Cancer in Premenopausal Women Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and gr ... Read More

    • Advanced Pancreatic Cancer - Pipeline Insight, 2024

      Advanced Pancreatic Cancer - Pipeline Insight, 2024 Advanced Pancreatic Cancer Overview ""Advanced Pancreatic Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Advanced Pancreatic Cancer mark ... Read More

    • Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

      Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. I ... Read More

    • Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024

      Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline ... Read More

    • Complex Regional Pain Syndrome - Pipeline Insight, 2024

      Complex Regional Pain Syndrome - Pipeline Insight, 2024 Complex Regional Pain Syndrome Overview ""Complex Regional Pain Syndrome Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Complex Regional Pa ... Read More

    • Neuropathic Pain - Pipeline Insight, 2024

      Neuropathic Pain - Pipeline Insight, 2024 Neuropathic Pain Overview ""Neuropathic Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neuropathic Pain market. A detailed picture of the Neuropathi ... Read More

    • Visceral Pain associated with GI disorders - Pipeline Insight, 2024

      Visceral Pain associated with GI disorders - Pipeline Insight, 2024 Visceral Pain associated with GI disorders Overview ""Visceral Pain associated with GI disorders Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

    • Chronic Lower Back Pain - Pipeline Insight, 2024

      Chronic Lower Back Pain - Pipeline Insight, 2024 DelveInsight’s, “Chronic Lower Back Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Lower Back Pain pipeline landscape. It covers the pipeline drug profiles, including clinic ... Read More

    • Ocular Pain - Pipeline Insight, 2024

      Ocular Pain - Pipeline Insight, 2024 DelveInsight’s, Ocular Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Ocular Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More

    • Chronic Back Pain - Pipeline Insight, 2024

      Chronic Back Pain - Pipeline Insight, 2024 Chronic Back Pain Overview ""Chronic Back Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Back Pain market. A detailed picture of the Chroni ... Read More

    • Sciatic Pain - Pipeline Insight, 2024

      Sciatic Pain - Pipeline Insight, 2024 Sciatic Pain Overview ""Sciatic Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Sciatic Pain market. A detailed picture of the Sciatic Pain pipeline land ... Read More

    • Ocular Inflammation and Pain - Pipeline Insight, 2024

      Ocular Inflammation and Pain - Pipeline Insight, 2024 DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ocular Inflammation and Pain pipeline landscape. It covers the pipeline drug profiles, inc ... Read More

    • Metastatic Bone Pain - Pipeline Insight, 2024

      Metastatic Bone Pain - Pipeline Insight, 2024 DelveInsight’s, “Metastatic Bone Pain – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Metastatic Bone Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

    • Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024

      Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024 Secondary Progressive Multiple Sclerosis (SPMS) Overview ""Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario ... Read More

    • Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024

      Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024 Chronic Progressive Multiple Sclerosis Overview ""Chronic Progressive Multiple Sclerosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

    • Transitional Cell Carcinoma - Pipeline Insight, 2024

      Transitional Cell Carcinoma - Pipeline Insight, 2024 Transitional Cell Carcinoma Overview ""Transitional Cell Carcinoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Transitional Cell Carcinoma ... Read More

    • Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024

      Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipel ... Read More

    • Obese patients with Schizophrenia - Pipeline Insight, 2024

      Obese patients with Schizophrenia - Pipeline Insight, 2024 Obese patients with Schizophrenia Overview ""Obese patients with Schizophrenia Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Obese pati ... Read More

    • Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2024

      Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2024 Systemic Juvenile Idiopathic Arthritis (SJIA) Overview ""Systemic Juvenile Idiopathic Arthritis (SJIA) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and gr ... Read More

10 11 12 13 14 15 16 17 18 19

Cookie Settings